Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elizabeth A. Morgenthien

Cardiovascular Risks, Bleeding Risks, and Clinical Events From 3 Phase III Trials of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Advances in Therapy

English

Related publications

Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal

Respiratory Medicine

English

Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis

Internal Medicine

Internal Medicine

English

Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis and More Advanced Lung Function Impairment

Respiratory Medicine

Respiratory Medicine

English

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

Annals of Thoracic Surgery

Respiratory Medicine

Cardiovascular Medicine

English

Pirfenidone Should Be Prescribed for Patients With Idiopathic Pulmonary Fibrosis: Table 1

Respiratory Medicine

English

Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis: Nationwide Danish Results

European Clinical Respiratory Journal

English

Idiopathic Pulmonary Fibrosis: Lessons From Clinical Trials Over the Past 25 Years

European Respiratory Journal

Respiratory Medicine

English

P196 Healthcare Utilisation by Patients With Idiopathic Pulmonary Fibrosis; Observations From the UK Pirfenidone Named Patient Programme

Respiratory Medicine

English

Cardiovascular Risk in Idiopathic Pulmonary Fibrosis

International Journal of Pulmonary & Respiratory Sciences

English